HYDERABAD, India--(BUSINESS WIRE)--May 31, 2006--Dr. Reddy’s Laboratories Ltd. (NYSE: RDY - News): Dr. Reddy’s Laboratories Ltd. (NYSE: RDY - News) today announced its audited financial results for the year ended March 31, 2006.
Revenues cross the $500 million milestone The Board of Directors recommend final dividend of 100% on face value of Rs. 5 per share The Board of Directors recommend the issue of bonus equity shares in the ratio of 1:1 (one equity share for each equity share held) Dr. Reddy’s compliant with section 404 of the U.S. Sarbanes Oxley Act - first manufacturing company in India
